MET Earning Date, Transcript Summary & Report

Earnings Increase Report: MetLife, Inc. reported adjusted earnings of $1.5 billion or $2.09 per share for Q4 2024, reflecting a 14% increase from the prior year period.

Adjusted Earnings Performance: For the full year 2024, adjusted earnings excluding notable items totaled $5.8 billion, driven by strong volume growth and favorable underwriting.

Adjusted Return on Equity: MetLife, Inc. achieved an adjusted return on equity of 15.2% for the year, exceeding the target range of 13% to 15%.

Group Benefits Earnings Growth: The group benefits business generated adjusted earnings of $1.7 billion in 2024, with full-year sales up 8% on strong growth in national accounts.

Shareholder Returns and Capital Management: In 2024, MetLife returned approximately $4.7 billion to shareholders through share repurchases and dividends, demonstrating strong capital management.

Group Benefits Earnings Decline: Group benefits adjusted earnings were $416 million, down 11% from the prior year quarter, primarily due to less favorable nonmedical health underwriting margins.

Q4 Earnings Decline: Retirement and income solutions (RIS) adjusted earnings were $386 million in Q4 of 2024, down 8% year-over-year, driven by lower recurring interest margins and less favorable underwriting.

Asia Sales Decline: Asia's sales were down 5% on a constant currency basis versus 2023, with Japan sales specifically down 18% year-over-year due to yen volatility.

Earnings Decline Forecast: MetLife Holdings adjusted earnings are expected to decline approximately 4% to 6% in 2025, with the business run-off accelerating to roughly 9% in 2024.

Increased Adjusted Loss: Corporate and other adjusted loss was $209 million, compared to an adjusted loss of $156 million in the prior year, reflecting higher expenses and taxes.